1-hexadecyl-2-acetyl-glycero-3-phosphocholine has been researched along with Insulin Resistance in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| DeFronzo, RA; Haywood, JR; Koopmans, SJ; Kudolo, GB | 1 |
| DeFronzo, RA; Kudolo, GB | 1 |
2 other study(ies) available for 1-hexadecyl-2-acetyl-glycero-3-phosphocholine and Insulin Resistance
| Article | Year |
|---|---|
Chronic hyperinsulinemia inhibits platelet-activating factor (PAF) biosynthesis in the rat kidney.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Acetyltransferases; Animals; Blood Pressure; Chronic Disease; Hyperinsulinism; Insulin; Insulin Resistance; Kidney; Male; Phospholipases A; Platelet Activating Factor; Rats; Rats, Sprague-Dawley | 1997 |
Urinary platelet-activating factor excretion is elevated in non-insulin dependent diabetes mellitus.
Topics: Adult; Blood Glucose; Body Mass Index; Diabetes Mellitus, Type 2; Humans; Insulin Resistance; Kidney Function Tests; Mexican Americans; Middle Aged; Platelet Activating Factor; Proteinuria | 1999 |